Crystalvue Medical Corporation (TPEX:6527)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
77.00
+2.50 (3.36%)
At close: Mar 6, 2026

Crystalvue Medical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,9511,9292,1522,1901,2411,144
Market Cap Growth
-8.44%-10.37%-1.77%76.51%8.45%-3.52%
Enterprise Value
1,8311,8361,8982,0091,0921,121
Last Close Price
77.0076.1082.7482.5246.1540.72
PE Ratio
13.5113.1216.9221.1810.7914.82
PS Ratio
2.062.032.482.661.561.59
PB Ratio
1.901.882.292.561.601.59
P/TBV Ratio
1.901.882.302.571.601.59
P/FCF Ratio
--95.1314.6428.05-
P/OCF Ratio
14.0313.8614.0614.2223.9718.09
EV/Sales Ratio
1.931.932.192.441.371.55
EV/EBITDA Ratio
9.219.2411.4514.407.599.15
EV/EBIT Ratio
10.1210.1513.0917.078.7512.67
EV/FCF Ratio
-40.77-83.9313.4224.69-
Debt / Equity Ratio
0.010.010.020.030.040.05
Debt / EBITDA Ratio
0.060.060.110.170.210.29
Debt / FCF Ratio
--0.820.170.71-
Net Debt / Equity Ratio
-0.12-0.12-0.24-0.29-0.19-0.22
Net Debt / EBITDA Ratio
-0.60-0.60-1.35-1.78-1.01-1.27
Net Debt / FCF Ratio
2.682.68-9.87-1.66-3.280.54
Asset Turnover
0.770.770.770.790.820.79
Inventory Turnover
2.402.402.082.052.362.88
Quick Ratio
1.441.441.841.971.621.62
Current Ratio
2.452.453.003.462.902.75
Return on Equity (ROE)
14.94%14.94%14.16%12.67%15.39%11.08%
Return on Assets (ROA)
9.12%9.12%8.01%7.03%7.99%6.06%
Return on Invested Capital (ROIC)
16.45%18.30%17.47%16.40%16.89%15.12%
Return on Capital Employed (ROCE)
17.50%17.50%15.20%13.40%15.50%11.80%
Earnings Yield
7.53%7.62%5.91%4.72%9.27%6.75%
FCF Yield
-2.30%-2.33%1.05%6.83%3.56%-25.16%
Dividend Yield
3.02%-2.72%2.51%4.95%4.54%
Payout Ratio
38.79%38.79%41.13%54.90%40.25%43.26%
Buyback Yield / Dilution
-0.38%-0.38%-1.64%0.91%-0.53%0.99%
Total Shareholder Return
2.64%-0.38%1.08%3.41%4.42%5.53%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.